Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
Completed · Not applicable
Conditions studied: Severe to Morbid Obesity and Type 2 Diabetes
In brief
The purpose of this study is to test the effect of an implanted device that stimulates the stomach on weight loss in patients suffering from obesity and type 2 diabetes.
Key facts
- Study ID
- NCT00200018
- Run by
- MedtronicNeuro
- People needed
- 46
- Starts
- 2005-06-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2009-02-05
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type 2 diabetes with HbA1c of 7.5 - 11%
- Willing to make behavior and lifestyle modifications
- No previous bariatric surgery (gastric bypass, gastric banding)
- Meet additional study criteria
You may not qualify if…
- History of substance abuse or chemical dependency with in the last 3 years
- Prior GI surgery for morbid obesity or any gastric surgery for conditions other than obesity or diabetes
- Severe congestive heart failure
- Any underlying illness other than diabetes or obesity that affects gastrointestinal motility
- Currently taking medications for weight loss
Where it is running
- Study site — La Jolla, California, United States
- Study site — Eagan, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.